[
    [
        {
            "time": "2023-08-30",
            "original_text": "凯莱英(002821.SZ)拟斥资9000万元参投三一众志二期基金",
            "features": {
                "keywords": [
                    "凯莱英",
                    "9000万元",
                    "参投",
                    "三一众志二期基金"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "投资"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "凯莱英(002821.SZ)拟斥资9000万元参投三一众志二期基金",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-08-30",
            "original_text": "凯莱英(002821.SZ)19.14万股限制性股票将于8月30日上市流通",
            "features": {
                "keywords": [
                    "凯莱英",
                    "19.14万股",
                    "限制性股票",
                    "上市流通"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英(002821.SZ)19.14万股限制性股票将于8月30日上市流通",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-08-30",
            "original_text": "凯莱英：约19.14万股限售股8月30日解禁，占比0.0789% 解禁",
            "features": {
                "keywords": [
                    "凯莱英",
                    "19.14万股",
                    "限售股",
                    "解禁"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英：约19.14万股限售股8月30日解禁，占比0.0789% 解禁",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]